货号:GS40814
Zansecimab (LY-3127804) is an investigational humanized monoclonal antibody of the IgG4-kappa isotype that selectively targets and neutralizes Angiopoietin-2 (Ang2). It is being developed as an anti-angiogenic and vascular-stabilizing agent, primarily for the treatment of neovascular age-related macular degeneration (AMD) and diabetic retinopathy, aiming to inhibit pathological blood vessel growth and leakage.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物